This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative central endothelial cell counts. The anticipated enrollment is 25 patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in central corneal pachymetry over time
Timeframe: Measured at post-operative month one visit and then every 2 months for 1 year
Change in endothelial cell count over time
Timeframe: Measured at post-operative month one visit and then every 2 months for 1 year